Abstract:Tumor-associated macrophages (TAMs) are predominantly present in the tumor microenvironment (TME) and play a crucial role in shaping the efficacy of tumor immunotherapy. These TAMs primarily exhibit a tumor-promoting M2-like phenotype, which is associated with the suppression of immune responses and facilitation of tumor progression. Interestingly, recent research has highlighted the potential of repolarizing TAMs from an M2 to a pro-inflammatory M1 status-a shift that has shown promise in impeding tumor growth and enhancing immune responsiveness. This concept is particularly intriguing as it offers a new dimension to cancer therapy by targeting the tumor microenvironment, which is a significant departure from traditional approaches that focus solely on tumor cells. However, the clinical application of TAM-modulating agents is often challenged by issues such as insufficient tumor accumulation and off-target effects, limiting their effectiveness and safety. In this regard, nanomaterials have emerged as a novel solution. They serve a dual role: as delivery vehicles that can enhance the accumulation of therapeutic agents in the tumor site and as TAM-modulators. This dual functionality of nanomaterials is a significant advancement as it addresses the key limitations of current TAM-modulating strategies and opens up new avenues for more efficient and targeted therapies. This review provides a comprehensive overview of the latest mechanisms and strategies involving nanomaterials in modulating macrophage polarization within the TME. It delves into the intricate interactions between nanomaterials and macrophages, elucidating how these interactions can be exploited to drive macrophage polarization towards a phenotype that is more conducive to anti-tumor immunity. Additionally, the review explores the burgeoning field of TAM-associated nanomedicines in combination with tumor immunotherapy. This combination approach is particularly promising as it leverages the strengths of both nanomedicine and immunotherapy, potentially leading to synergistic effects in combating cancer.

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Macrophage-modulating nanomedicine for cancer immunotherapy

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Recent Progress on Nanomedicine-Mediated Repolarization of Tumor-Associated Macrophages for Cancer Immunotherapy

Reprogramming Tumor Associated Macrophages Toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy

Nanomaterials-Involved Tumor-Associated Macrophages' Reprogramming for Antitumor Therapy

Advance of nano anticancer therapies targeted on tumor-associated macrophages

Harnessing Anti‐tumor and Tumor‐tropism Functions of Macrophages Via Nanotechnology for Tumor Immunotherapy

Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies

Nanomedicine enables spatiotemporally regulating macrophage-based cancer immunotherapy

Modulation of Tumor Microenvironment for Immunotherapy: Focus on Nanomaterial-Based Strategies

Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages

Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.